Subgroup outcomes from RAISE: A randomized, Phase 3 trial of zilucoplan in generalized myasthenia gravis

被引:0
|
作者
Weiss, Michael D. [1 ]
Bresch, Saskia [2 ]
Freimer, Miriam [3 ]
Hewamadduma, Channa [4 ]
Juntas-Morales, Raul [5 ]
Leite, M. Isabel [6 ]
Maniaol, Angelina [7 ]
Masuda, Masayuki [8 ]
Sivakumar, Kumaraswamy [9 ]
Zajda, Malgorzata [10 ]
Boroojerdi, Babak [11 ]
Duda, Petra W. [12 ]
De La Borderie, Guillemette [13 ]
Howard, James F., Jr. [14 ]
机构
[1] Univ Washington, Med Ctr, Dept Neurol, Seattle, WA USA
[2] Ctr Hosp Univ Nice, Nice, France
[3] Ohio State Univ, Columbus, OH USA
[4] Univ Sheffield, Dept Neurosci, Sheffield, S Yorkshire, England
[5] Vall dHebron Univ Hosp, Barcelona, Spain
[6] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England
[7] Oslo Univ Hosp, Dept Neurol, Oslo, Norway
[8] Tokyo Med Univ, Dept Neurol, Tokyo, Japan
[9] Univ Arizona, Sch Med, Neuromuscular Clin & Res Ctr, Tucson, AZ USA
[10] Med Univ Warsaw, Warsaw, Poland
[11] UCB Pharma, Monheim, Germany
[12] UCB Pharma, Cambridge, MA USA
[13] UCB Pharma, Brussels, Belgium
[14] Univ N Carolina, Dept Neurol, Chapel Hill, NC USA
关键词
D O I
10.1212/WNL.0000000000202904
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P1-5.006
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Randomized trial of thymectomy in myasthenia gravis
    Wolfe, Gil I.
    Kaminski, Henry J.
    Sonnett, Joshua R.
    Aban, Inmaculada B.
    Kuo, Hui-Chien
    Cutter, Gary R.
    JOURNAL OF THORACIC DISEASE, 2016, 8 (12) : E1782 - E1783
  • [22] Efgartigimod in Myasthenia Gravis: Phase 3 Trial Design
    Howard, J. F., Jr.
    De Haard, H.
    Parys, W.
    Ulrichts, P.
    Guglietta, A.
    Mantegazza, R. E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 353 - 353
  • [23] Randomized Trial of Thymectomy in Myasthenia Gravis
    Wolfe, G. I.
    Kaminski, H. J.
    Aban, I. B.
    Minisman, G.
    Kuo, H-C
    Marx, A.
    Strobel, P.
    Mazia, C.
    Oger, J.
    Cea, J. G.
    Heckmann, J. M.
    Evoli, A.
    Nix, W.
    Ciafaloni, E.
    Antonini, G.
    Witoonpanich, R.
    King, J. O.
    Beydoun, S. R.
    Chalk, C. H.
    Barboi, A. C.
    Amato, A. A.
    Shaibani, A. I.
    Katirji, B.
    Lecky, B. R. F.
    Buckley, C.
    Vincent, A.
    Dias-Tosta, E.
    Yoshikawa, H.
    Waddington-Cruz, M.
    Pulley, M. T.
    Rivner, M. H.
    Kostera-Pruszczyk, A.
    Pascuzzi, R. M.
    Jackson, C. E.
    Ramos, G. S. Garcia
    Verschuuren, J. J. G. M.
    Massey, J. M.
    Kissel, J. T.
    Werneck, L. C.
    Benatar, M.
    Barohn, R. J.
    Tandan, R.
    Mozaffar, T.
    Conwit, R.
    Odenkirchen, J.
    Sonett, J. R.
    Jaretzki, A., III
    Newsom-Davis, J.
    Cutter, G. R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (06): : 511 - 522
  • [24] Subgroup stratification and outcome in recently diagnosed generalized myasthenia gravis
    Tomschik, Matthias
    Hilger, Eva
    Rath, Jakob
    Mayer, Eva-Maria
    Fahrner, Michael
    Cetin, Hakan
    Loescher, Wolfgang N.
    Zimprich, Fritz
    NEUROLOGY, 2020, 95 (10) : E1426 - E1436
  • [25] LETTER RE: A RANDOMIZED CONTROLLED TRIAL OF METHOTREXATE FOR PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS
    Kelkar, Praful
    Valley, Golden
    NEUROLOGY, 2017, 88 (04) : 417 - 417
  • [26] An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis
    Sanders, D. B.
    Hart, I. K.
    Mantegazza, R.
    Shukla, S. S.
    Siddiqi, Z. A.
    De Baets, M. H. V.
    Melms, A.
    Nicolle, M. W.
    Solomons, N.
    Richman, D. P.
    NEUROLOGY, 2008, 71 (06) : 400 - 406
  • [27] CORTICOSTEROID DOSE TAPERING DURING TREATMENT WITH ZILUCOPLAN IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: 120-WEEK FOLLOW-UP OF RAISE-XT
    Freimer, Miriam
    Genge, Angela
    Hewamadduma, Channa
    Leite, M. Isabel
    Utsugisawa, Kimiaki
    Vu, Tuan
    Boroojerdi, Babak
    Grimson, Fiona
    Savic, Natasa
    Vanderkelen, Mark
    Howard, James F., Jr.
    MUSCLE & NERVE, 2024, 70 (03) : 528 - 528
  • [28] Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis
    Howard, James F., Jr.
    Bril, Vera
    Burns, Ted M.
    Mantegazza, Renato
    Bilinska, Malgorzata
    Szczudlik, Andrzej
    Beydoun, Said
    De Rivera Garrido, Francisco Javier Rodriguez
    Piehl, Fredrik
    Rottoli, Mariarosa
    Van Damme, Philip
    Tuan Vu
    Evoli, Amelia
    Freimer, Miriam
    Mozaffar, Tahseen
    Ward, E. Sally
    Dreier, Torsten
    Ulrichts, Peter
    Verschueren, Katrien
    Guglietta, Antonio
    de Haard, Hans
    Leupin, Nicolas
    Verschuuren, Jan J. G. M.
    Claeys, Kristl
    Diez-Tejedor, Exuperio
    Mathew, Veena
    Sgarzi, Manlio
    Harvey, Brittany Leigh
    Farias, Jerrica
    Frangiomore, Rita
    Heintzman, Sarah
    de Meel, Robert
    Chopra, Manisha
    Alboini, Paolo Emilio
    Hietala, Albert
    Genge, Angela
    NEUROLOGY, 2019, 92 (23) : E2661 - E2673
  • [29] SAFETY AND TOLERABILITY OF ZILUCOPLAN IN RAISE-XT: A MULTICENTER, OPEN-LABEL EXTENSION STUDY IN PATIENTS WITH MYASTHENIA GRAVIS
    Genge, Angela
    Hussain, Yessar
    Kaminski, Henry J.
    Leite, M. Isabel
    Mantegazza, Renato
    Utsugisawa, Kimiaki
    Vu, Tuan
    Brock, Melissa
    Boroojerdi, Babak
    Vanderkelen, Mark
    de la Borderie, Guillemette
    Duda, Petra W.
    Howard, James F., Jr.
    MUSCLE & NERVE, 2022, 66 : S131 - S131
  • [30] Commentary on "Randomized trial of thymectomy in myasthenia gravis"
    Tzankov, Alexandar
    JOURNAL OF THORACIC DISEASE, 2016, 8 (10) : E1420 - E1422